by Andrea Fenton Abbs | Jan 10, 2023 | BRIGHT Culture
More than a buzzword, sustainability is both a priority and a passion at BRIGHT. We’re committed to building a sustainable business for the benefit of our employees, clients, and business partners. In this article, I’m excited to share the intentional approaches we...
by Andrea Fenton Abbs | Jul 12, 2022 | Study Execution
A well-planned site selection process is essential for the smooth execution of your clinical study. How do you choose the best sites considering all the choices available? Do you need a key opinion leader (KOL) as your national principal investigator? Some sites are...
by Andrea Fenton Abbs | Jan 25, 2022 | ClinReg Strategy
Most leadership teams would agree that it is better to meet the timeline of a well-thought-out clinical study schedule than repeatedly miss the mark on an over-zealous one, even if the timeline is longer. No matter what your advisors told you, do not commit to your...
by Andrea Fenton Abbs | Dec 14, 2021 | BRIGHT Culture
We’re taking time to reflect on the blog topics we shared in 2021, the experience we gained, and the inspiring work we did to help clients strategize, design, and execute successful clinical studies to meet their goals. These achievements were all made possible by the...
by Andrea Fenton Abbs | Nov 9, 2021 | Study Execution
When a clinical study will be used to support an FDA market authorization application, it’s likely the agency will require a Bioresearch Monitoring (BIMO) inspection. Similar to our advice on clinical study design, it’s critical to “begin with the end in mind,”...
